Evidence map›Paper›PMID 40181185›Full record

ArticleEMBO molecular medicine2025

Getting to the heart of cardiovascular complications associated with inflammatory arthritis.

Hong Shi, Brian H Annex

Abstract read
In one paragraph

Article in EMBO molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hong ShiDivision of Rheumatology, Medical College of Georgia at Augusta University, Augusta, GA, 30909, USA.ORCID http://orcid.org/0000-0002-9642-2317
Brian H AnnexDivision of Cardiology, Department of Medicine, Medical College of Georgia at Augusta University, Augusta, GA, 30909, USA. bannex@augusta.edu.ORCID http://orcid.org/0000-0001-6538-8243

Funding

Precision Medicine for Therapeutic Angiogenesis in Peripheral Arterial Disease: Targeting of the IL21R PathwayR01HL148590 · NHLBI · AUGUSTA UNIVERSITY · PI ANNEX, BRIAN H · 2019 to 2022
$2.9M
Mechanistic basis of sexual dimorphism in antigen-independent IgG1 angiogenesis regulationR01HL164592 · NHLBI · UNIVERSITY OF VIRGINIA · PI Bradley David Gelfand · 2023 to 2026
$2.7M
Perivascular adipose tissue in the pathogenesis of lupus vasculopathyK08AR082453 · NIAMS · AUGUSTA UNIVERSITY · PI Hong Shi · 2024 to 2026
$531k
American Heart Association (AHA) 24SCEFIA1263343National Institute of Health K08AR082453National Institute of Health. Heart Lung and Blood RO1HL164592National Institute of Health. Heart Lung, and Blood RO1HL148590National Institute of Health. Heart, Lung, and Blood RO1HL15003NHLBI NIH HHS R01 HL148590NHLBI NIH HHS R01 HL164592NIAMS NIH HHS K08 AR082453
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40181185
PMCPMC12081766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.